Miriam has over 16 years of experience working in Biotechnology and CRO settings. Starting her career in Germany, she gained work experience in Germany and the UK; moving to Australia gave her the opportunity to work in a global context and gain expertise within the Asia-Pacific region, managing clinical trials with local and global clients.
Her experience covers a diversity of project management roles across multiple therapeutic areas in all stages of clinical development, as well as people management.
Miriam is responsible for implementing Actinogen’s clinical development plan for Xanamem, including CRO and vendor management, and overseeing Grant applications.
LinkedIn Profile: linkedin.com/in/miriam-roesner